title: Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis.
abstract: Honey is a complex mixture of different biologically active constituents. Honey possesses anti-inflammatory, antioxidant and antitumor properties. Our chief investigation was to assess the honey induced apoptosis and its molecular mechanism in colon cancer cell growth inhibition. Honey exerted antiproliferative potential against the HCT-15 and HT-29 colon cancer cells as assessed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. Flow cytometric analysis showed the increasing accumulation of hypodiploid nuclei in the sub-G(1) phase of cell cycle indicating apoptosis. Honey transduced the apoptotic signal via initial depletion of intracellular non protein thiols, consequently reducing the mitochondrial membrane potential (MMP) and increasing the reactive oxygen species (ROS) generation. An increasing earlier lipid layer break was observed in the treated cells compared to the control. Honey induced apoptosis was accompanied by up-regulating the p53 and modulating the expression of pro and anti-apoptotic proteins. Further apoptosis induction was substantiated using DNA fragmentation assay and YO-PRO-1 staining. Results showed honey as a plausible candidate for induction of apoptosis through ROS and mitochondria-dependent mechanisms in colon cancer cells. This will promote honey as a potential chemotherapeutic agent against colon cancer.
authors.affiliation: School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, 721 302, West Bengal, India.
authors.forename: Saravana Kumar
authors.initials: SK
authors.lastname: Jaganathan
authors.forename: Mahitosh
authors.initials: M
authors.lastname: Mandal
mesh_terms: D017209:Apoptosis; D015153:Blotting, Western; D002453:Cell Cycle; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D048429:Cell Size; D005434:Flow Cytometry; D019073:HT29 Cells; D006722:Honey; D006801:Humans; D008055:Lipids / Q000737:chemistry; D053078:Membrane Potential, Mitochondrial; D008928:Mitochondria / Q000473:pathology*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D008055:Lipids; D017382:Reactive Oxygen Species; D013438:Sulfhydryl Compounds; D016159:Tumor Suppressor Protein p53
references.citation: Biochem Biophys Res Commun. 2004 Dec 24;325(4):1215-22
references.pmid: 15555556
references.citation: Mol Cell Biol. 2003 Dec;23(23):8576-85
references.pmid: 14612402
references.citation: J Biomed Sci. 2000 Jan-Feb;7(1):2-15
references.pmid: 10644884
references.citation: Life Sci. 2001 Sep 7;69(16):1833-50
references.pmid: 11693264
references.citation: Apoptosis. 2007 Jan;12(1):113-23
references.pmid: 17136495
references.citation: Nat Prod Res. 2010 Sep;24(14):1295-306
references.pmid: 20803373
references.citation: J Biol Chem. 1996 Mar 22;271(12):6746-51
references.pmid: 8636095
references.citation: Arch Biochem Biophys. 2000 Feb 15;374(2):142-52
references.pmid: 10666292
references.citation: J Pharmacol Exp Ther. 2001 Jan;296(1):1-6
references.pmid: 11123355
references.citation: Biotechniques. 2001 Jun;30(6):1322-6, 1328, 1330-1
references.pmid: 11414226
references.citation: Cancer Lett. 2004 May 28;208(2):143-53
references.pmid: 15142672
references.citation: Plant Physiol. 2002 Jan;128(1):63-72
references.pmid: 11788753
references.citation: Oncogene. 2000 Jan 13;19(2):307-14
references.pmid: 10645010
references.citation: Cancer Lett. 2006 Nov 8;243(1):80-9
references.pmid: 16413113
references.citation: Int J Urol. 2003 Apr;10(4):213-9
references.pmid: 12657101
references.citation: Vopr Onkol. 1990;36(6):704-9
references.pmid: 2378090
references.citation: Cancer Res. 1993 Sep 15;53(18):4182-8
references.pmid: 8364913
references.citation: Curr Opin Cell Biol. 1995 Jun;7(3):337-43
references.pmid: 7662363
references.citation: J Biomed Biotechnol. 2009;2009:830616
references.pmid: 19636435
references.citation: Biochem Pharmacol. 2003 Dec 15;66(12):2281-9
references.pmid: 14637186
references.citation: Immunol Today. 1994 Jan;15(1):7-10
references.pmid: 8136014
references.citation: Nature. 2000 Oct 12;407(6805):770-6
references.pmid: 11048727
references.citation: Cancer Lett. 2005 Jul 8;225(1):41-52
references.pmid: 15922856
references.citation: Vet Comp Oncol. 2003 Dec;1(4):216-26
references.pmid: 19379183
references.citation: Biofactors. 1998;8(1-2):1-5
references.pmid: 9699000
references.citation: Toxicol Appl Pharmacol. 1997 Apr;143(2):397-406
references.pmid: 9144456
references.citation: Cell Death Differ. 2000 Mar;7(3):314-26
references.pmid: 10745276